Statement:
Acknowledgment:
Authors would like to acknowledge the internal medicine and hematology
departments at Hamad Medical Corporation for supporting this
publication.
Statement of ethics:
Written informed consent was obtained from the patient to allow the
publication of information including images.
Case approved by HMC Medical Research Center.
Disclosure Statement:
The authors report no conflicts of interest in this work.
Funding sources
Qatar National Library.
Author’s contribution:
All authors contributed equally in writing and editing.
References
1- Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN,
Weatherall DJ, Hay SI. Global distribution of the sickle cell gene and
geographical confirmation of the malaria hypothesis. Nat Commun 1, 104.
2- Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. The Lancet.
2010 Dec 11;376(9757):2018-31.
3- Fucharoen S, Weatherall DJ. The hemoglobin E thalassemias. Cold
Spring Harbor perspectives in medicine. 2012 Aug 1;2(8):a011734.
4- Farooq S, Abu Omar M, Salzman GA. Acute chest syndrome in sickle cell
disease. Hospital Practice. 2018 May 27;46(3):144-51.
5- Tay SH, Teng GG, Poon M, Lee VK, Lim AY. A case of hemoglobin SE
presenting with sickle cell crisis: case report and histological
correlation. Annals of the Academy of Medicine, Singapore. 2011 Dec
1;40(12):552-3.
6- Eichhorn RF, Buurke EJ, Blok P, Berends MJ, Jansen CL. Sickle
cell‐like crisis and bone marrow necrosis associated with parvovirus B19
infection and heterozygosity for haemoglobins S and E. Journal of
internal medicine. 1999 Jan;245(1):103-6.
7- Malowany JI, Butany J. Pathology of sickle cell disease. InSeminars
in diagnostic pathology 2012 Feb 1 (Vol. 29, No. 1, pp. 49-55). WB
Saunders.
8- Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease and
assessment of risk factors based on transcranial Doppler values in the
Gulf region. Hematology. 2020 Jan 1;25(1):55-62.
9- Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D,
Akenova A, Akinyanju O, Cinkotai K, O’reilly PH. Priapism in sickle‐cell
disease; incidence, risk factors and complications–an international
multicentre study. BJU international. 2002 Dec;90(9):898-902.
10- Shier A, Abdelrazek M, Soliman A, De Sanctis V, Elsayed A, Abdulla
M, Mohamed S, Yassin K, Bilal I, Yassin M. Short-Term Outcome and MRI
Changes in Three Adult Patients with Sickle Cell Disease and Aseptic
Osteonecrosis after Treatment with Hyperbaric Oxygen Therapy: A
Preliminary Report. Case Reports in Oncology. 2020;13(1):365-72.
11- Masiello D, Heeney MM, Adewoye AH, Eung SH, Luo HY, Steinberg MH,
Chui DH. Hemoglobin SE disease—a concise review. American journal of
hematology. 2007 Jul;82(7):643-9.
12- Acipayam C, Oktay G, Ilhan G, Çürük MA. Hemoglobin SE disease in
Hatay, in the southern part of Turkey. Thalassemia Reports. 2015 Feb 25.
13- Rayburg M, Kalinyak KA, Towbin AJ, Baker PB, Joiner CH. Fatal bone
marrow embolism in a child with hemoglobin SE disease. American journal
of hematology. 2010 Mar;85(3):182-4.
14- George E, Iqbal QM. Hb ES presenting as avascular necrosis. The
Southeast Asian journal of tropical medicine and public health. 1978
Dec;9(4):568.
15- ENGELSTAD BL. Functional asplenia in hemoglobin SE disease. Clinical
nuclear medicine. 1982 Mar 1;7(3):100-2.
16- Knox‐Macaulay HH, Ahmed MM, Gravell D, Al‐Kindi S, Ganesh A. Sickle
cell–haemoglobin E (HbSE) compound heterozygosity: a clinical and
haematological study. International journal of laboratory hematology.
2007 Aug;29(4):292-301.
Figure legends:
Table 1: laboratory investigations
Figure 1: chest x-ray
Table 2: Hemoglobin electrophoresis